The Corpus Luteum of Pregnancy

The Ovary: Second Edition

Volumn , Issue , 2003, Pages 201-230

  Bowen Shauver, Jennifer M ^a   Gibori, Geula ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942784553     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012444562-8/50013-6     Document Type: Chapter

References (384)

1. Falloppio G. Observationes Anatomicae 1561, translator L. G. Wilson. Venice.
2. de Graaf R. De Mulerium Organis Generationi Inservientibus Tractatus Novus 1672, Hackiana, Leydon, The Netherlands.
3. Malpighi M. Praeclarissimo et Eruditissimo Viro D. Jacobo Sponio Medicinae Doctori et Lugdeunensi Anatomico Accuratissimo. Phil. Trans. R. Soc. (Lond.) 1685, 14:630.
4. Short R.V. The discovery of the ovaries. The Ovary 1977, 1-40. Academic Press, New York. 2d ed. P.L. Zuckermann, B.J. Weir (Eds.).
5. Prenant A. La valeur morphologique du corps jaune. Son action physiologique et therapeutique possible. Rev. Gen. Scie. Pure. Appl. 1898, 9:646-650.
6. Fraenkel L. Die function des corpus luteum. Arch. Gynaekol. 1903, 68:438-545.
7. Fraenkel L., Cohn F. Experimentalle untersuchungen uber den einfluss des corpus luteum auf de insertion des eies. Anat. Anz. 1901, 20:294-300.
8. Magnus V. Ovariets betydning for svangerskabet med saerligt hensyn til corpus luteum. Nor. Mag. Laegevidensk. 1901, 62:1138-1145.
9. Allen W.M., Corner G.W. Physiology of the corpus luteum. VII. Maintenance of pregnancy in the rabbit after very early castration by corpus luteum extract. Proc. Soc. Exp. Biol. Med. 1929, 27:403-405.
10. Allen M.W., Wintersteiner O. Crystalline progestin. Science 1934, 80:190-191.
11. Butenandt A., Westphal U., Cobler H. Uber einen abbau des stigma-sterins zu corpus-luteum-work-samen stoffen; ein beltrag zur konstitution des corpus-luteum-hormons (vorlauf mitteil). Ber. Dtsch. Chem. Ges. 1934, 67:1611-1616.
12. Hartmann M., Wettstein A. Zur kenntis der corpus-luteum hormone (2. Mitteilung). Helv. Chem. Acta. 1934, 17:1365-1370.
13. Slotta K.H., Rushig H., Fells W. Reindarstellung der hormone aus dem corpus luteum. Ber. Dtsch. Chem. Ges. 1934, 67:1270.
14. Richards J.S., Russell D.L., Ochsner S., Espey L.L. Ovulation: New dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 2002, 64:69-92.
15. Richards J.S. Perspective: The ovarian follicle-a perspective in 2001. Endocrinology 2001, 142:2184-2193.
16. Kip1. Mol. Endocrinol. 1998, 12:924-940.
17. Robker R.L., Richards J.S. Hormonal control of the cell cycle in ovarian cells: Proliferation versus differentiation. Biol. Reprod. 1998, 59:476-482.
18. Kip1. Cell 1996, 85:721-732.
19. Hampl A., Pacherník J., Dvorák P. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice. Biol. Reprod. 2000, 62:1393-1401.
20. Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa-luteal transition. Cell Growth Differ. 1998, 9:787-794.
21. Kaynard A.H., Periman L.M., Simard K., Melner M.H. Ovarian 3β-hydroxysteroid dehydrogenase and sulfated glycoprotein-2 gene expression are differentially regulated by the induction of ovulation, pseudopregnancy, and luteolysis in the immature rat. Endocrinology 1992, 130:2192-2200.
22. Doody K.J., Lorence M.C., Mason J.I., Simpson E.R. Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J. Clin. Endocrinol. Metab. 1990, 70:1041-1045.
23. Doody K.J., Lephard E.D., Stirling D., Lorence M.C., Magness R.R., McPhaul M.J., Simpson E.R. Expression of mRNA species encoding steroidogenic enzymes in the rat ovary. J. Mol. Endocrinol. 1991, 6:153-162.
24. Goldring N.B., Durica J.M., Lifka J., Hedin L., Ratoosh S.L., Miller W.L., Orly J., Richards J.S. Cholesterol side-chain cleavage P450 (P450scc) mRNA: Evidence for hormonal regulation in rat ovarian follicles and constitutive expression in corpora lutea. Endocrinology 1987, 120:1942-1950.
25. Kiriakidou M., McAllister J.M., Sugawara T., Strauss J.F. Expression of steroidogenic acute regulatory protein (StAR) in the human ovary. J. Clin. Endocrinol. Metab. 1996, 81:4122-4128.
26. Sandhoff T.W., McLean M.P. Hormonal regulation of steroidogenic acute regulatory (StAR) protein messenger ribonucleic acid expression in the rat ovary. Endocrine 1996, 4:259-267.
27. Hickey G.J., Chen S.A., Besman M.J., Shively J.E., Hall P.F., Gaddy-Kurten D., Richards J.S. Hormonal regulation, tissue distribution, and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: Relationship to estradiol biosynthesis. Endocrinology 1988, 122:1426-1436.
28. Keyes P.L., Wiltbank M.C. Endocrine regulation of the corpus luteum. Annu. Rev. Physiol. 1988, 50:465-482.
29. Camp T.A., Rahal J.O., Mayo K.E. Cellular localization and hormonal regulation of follicle-stimulating hormone and lutenizing hormone receptor messenger RNAs in the rat ovary. Mol. Endocrinol. 1991, 5:1405-1417.
30. Russell D.L., Richards J.S. Differentiation-dependent PRL responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol. Endocrinol. 1999, 13:2049-2064.
31. Telleria C.M., Parmer T.G., Zhong L., Clarke D.L., Albarracin C.T., Duan W.R., Linzer D.I., Gibori G. The different forms of the PRL receptor in the rat corpus luteum: Developmental expression and hormonal regulation in pregnancy. Endocrinology 1997, 138:4812-4820.
32. Clarke D.L., Linzer D.I.H. Changes in prolactin receptor expression during pregnancy in the mouse ovary. Endocrinology 1993, 133:224-232.
33. Ruff S.J., Leers-Sucheta S., Melner M.H., Cohen S. Induction and activation of Stat 5 in the ovaries of pseudopregnant rats. Endocrinology 1996, 137:4095-4099.
34. Hsieh M., Johnson M.A., Greenberg N.M., Richards J.S. Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. Endocrinology 2002, 143:898-908.
35. Richards J.S., Sharma S.C., Falender A.E., Lo Y.H. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: Evidence for regulation by IGF-1, estrogen, and the gonadotropins. Mol. Endocrinol. 2002, 16:580-599.
36. Alliston T.N., Gonzalez-Robayna I.J., Buse P., Fireston G.L., Richards J.S. Expression and localization of serum/glucocorticoid-induced kinase in the rat ovary: Relation to follicular growth and differentiation. Endocrinology 2000, 141:385-395.
37. Sharma S.C., Richards J.S. Regulation of AP1 (Jun/Fos) factor expression and activation in ovarian granulosa cells: Relation of JunD and Fra2 to terminal differentiation. J. Biol. Chem. 2000, 275:33718-33728.
38. Curry T.E., Song L., Wheeler S.E. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol. Reprod. 2001, 65:855-865.
39. Curry T.E., Osteen K.G. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol. Reprod. 2001, 64:1285-1296.
40. Dickson S.E., Fraser H.M. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. J. Clin. Endocrinol. Metab. 2000, 85:2339-2344.
41. Wulff C., Wilson H., Largue P., Duncan W.C., Armstrong D.G., Fraser H.M. Angiogenesis in the human corpus luteum: Localization and changes in angiopoietins, Tie-2 and vascular endothelial growth factor messenger ribonucleic acid. J. Clin. Endocrinol. Metab. 2000, 85:4302-4309.
42. Wulff C., Dickson S.E., Duncan W.C., Fraser H.M. Angiogenesis in the human corpus luteum: Simulated early pregnancy by hCG treatment is associated with both angiogenesis and vessel stabilization. Hum. Reprod. 2001, 16:2515-2524.
43. Lee A., Christenson L.K., Patton P.E., Burry K.A., Stouffer R.L. Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum. Reprod. 1997, 12:2756-2761.
44. Geva E., Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil. Steril. 2000, 74:429-438.
45. Rowe A.J., Morris K.D., Bicknell R., Fraser H.M. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Biol. Reprod. 2002, 67:1180-1188.
46. Christenson L.K., Stouffer R.L. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 1996, 137:367-374.
47. Rodger F.E., Young F.M., Fraser H.M., Illingworth P.J. Endothelial cell proliferation follows the midcycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum. Reprod. 1997, 12:1723-1729.
48. Meyer G.T., Bruce N.W. Quantitative cell changes and vascularization in the early corpus luteum of the pregnant rat. Anat. Rec. 1980, 197:369-374.
49. Tamura H., Greenwald G. Angiogenesis and its hormonal control in the corpus luteum of the pregnant rat. Biol. Reprod. 1987, 36:1149-1154.
50. Meyer G.T., McGeachie J.K. Angiogenesis in the developing corpus luteum of pregnant rats: A sterologic and autoradiographic study. Anat. Rec. 1988, 222:18-25.
51. Reynolds L.P., Grazul-Bilska A.T., Redmer D.A. Angiogenesis in the corpus luteum. Endocrine 2000, 12:1-9.
52. Stouffer R.L., Martinez-Chequer J.C., Molskness T.A., Xu F., Hazzard T.M. Regulation and action of angiogenic factors in the primate ovary. Arch. Med. Res. 2001, 32:567-575.
53. Reynolds L.P., Redmer D.A. Growth and development of the corpus luteum. J. Reprod. Fertil. Suppl. 1999, 54:181-191.
54. Goede V., Schmidt T., Kimmina S., Kozian D., Augustin H.G. Analysis of blood vessel maturation. Lab. Invest. 1998, 78:1385-1394.
55. Wiltbank M.C., Dysko R.C., Gallagher K.P., Keyes P.L. Relationship between blood flow and steroidogenesis in the rabbit corpus luteum. J. Reprod. Fertil. 1988, 84:513-520.
56. Talks K.L., Harris A.L. Current status of antiangiogenic factors. Br. J. Haematol. 2000, 109:477-489.
57. Ny T., Wahlberg P., Brandstrom I.J.M. Matrix remodeling in the ovary: Regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol. Cell. Endocrinol. 2002, 187:29-38.
58. Duncan W.C. The human corpus luteum: Remodelling during luteolysis and maternal recognition of pregnancy. Rev. Reprod 2000, 5:12-17.
59. Nothnick W.B., Keeble S.C., Curry T.E. Collagenase, gelatinase, and proteoglycanase mRNA expression and activity during luteal development, maintenance, and regression in the pseudopregnant rat ovary. Biol. Reprod. 1996, 54:616-624.
60. Liu K., Olofsson J.I., Wahlberg P., Ny T. Distinct expression of gelatinase A (matrix metalloproteinase [MMP-2]), collagenase-3 (MMP-13), membrane type MMP1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum. Endocrinology 1999, 140:5330-5338.
61. Li Q.L., Wang H.M., Lin H.Y., Liu D.L., Zhang X., Liu G.Y., Qian D., Zhu C. Expression of gelatinases and their tissue inhibitors in rat corpus luteum during pregnancy and postpartum. Mol. Reprod. Dev. 2000, 63:273-281.
62. Duncan W.C., McNeilly A.S., Illingworth P.J. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum. J. Clin. Endocrinol. Metab. 1998, 83:2470-2478.
63. Gaddy-Kurten D., Hicky G.J., Fey G.H., Gauldie J., Richards J.S. Hormonal regulation and tissue-specific localization of alpha 2-macroglobulin in rat ovarian follicles and corpora lutea. Endocrinology 1989, 125:2985-2995.
64. Liu K., Brandstrom A., Liu Y.-X., Ny T., Selstam G. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat. Endocrinology 1996, 137:2126-2132.
65. Wang Z., Juttermann R., Soloway P.D. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 2000, 275:26411-26415.
66. Nothnick W.B. Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice. Biol. Reprod. 2000, 63:905-912.
67. Umans L., Serneels L., Overbergh L., Lorent K., Van Leuven F., Van den Berghe H. Targeted inactivation of the mouse alpha 2-macroglobulin gene. J. Biol. Chem. 1995, 270:19778-19785.
68. Ferrarra N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997, 18:4-25.
69. Park J.E., Keller G.A., Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extra-cellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell. 1993, 4:1317-1326.
70. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 1994, 269:26988-26995.
71. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735-745.
72. Gluzman-Poltorak Z., Cohen T., Herzog Y., Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem. 2000, 275:18040-18045.
73. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
74. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
75. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
76. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70.
77. Bellomo D., Headrick J.P., Silins G.U., Paterson C.A., Thomas P.S., Gartside M., Mould A., Cahill M.M., Tonks I.D., Grimmond S.M., Townson S., Wells C., Little M., Cummings M.C., Kay G.F. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 2000, 86:E29-E35.
78. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 1993, 91:2235-2243.
79. Hazzard T.M., Christenson L.K., Stouffer R.L. Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol. Hum. Reprod. 2000, 6:993-998.
80. Endo T., Kitajima Y., Nishikawa A., Manase K., Shibuya M., Kudo R. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea. Fertil. Steril. 2001, 76:762-768.
81. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 1995, 146:157-165.
82. Gordon J.D., Mesiano S., Zaloudek C.J., Jaffe R.B. Vascular endothelial growth factor localization in human ovary and fallopian tubes: Possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab. 1996, 81:353-359.
83. Otani N., Minami S., Yamoto M., Shikone T., Otani H., Nishiyama R., Otani T., Nakano R. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J. Clin. Endocrinol. Metab. 1999, 84:3845-3851.
84. Yamamoto S., Konishi I., Tsuruta Y., Nanbu K., Mandai M., Kuroda H., Matsushita K., Hamid A.A., Yura Y., Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol. Endocrinol. 1997, 11:371-381.
85. Sugino N., Kashida S., Takiguchi S., Karube-Harada A., Kato H. Expression of vascular endothelial growth factor (VEGF) receptors in rat corpus luteum: Regulation by oestradiol during mid-pregnancy. Reproduction 2001, 122:875-881.
86. Sugino N., Kashida S., Takiguchi S., Karube A., Kato H. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J. Clin. Endocrinol. Metab. 2000, 85:3919-3924.
87. A40. J. Clin. Endocrinol. Metab. 2001, 86:3377-3386.
88. Kashida S., Sugino N., Takiguchi S., Karube A., Takayama H., Yamagata Y., Nakamura Y., Kato H. Regulation and role of vascular endothelial growth factor in the corpus luteum during mid-pregnancy in rats. Biol. Reprod. 2001, 64:317-323.
89. Zimmerman R.C., Hartman T., Bohlen P., Sauer M.V., Kitajewski J. Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. Microvasc. Res. 2001, 62:15-25.
90. Ferrara N., Chen H., Davis-Smyth T., Gerber H.P., Nguyen T.N., Peers D., Chisholm V., Hillan K.J., Schwall R.H. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 1998, 4:336-340.
91. Hazzard T.M., Xu F., Stouffer R.L. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol. Reprod. 2002, 67:1305-1312.
92. Dickson S.E., Bicknell R., Fraser H.M. Mid-luteal angiogenesis and function in the primate is dependent upon vascular endothelial growth factor. J. Endocrinol. 2001, 168:409-416.
93. Fraser H.M., Dickson S.E., Lunn S.F., Wulff C., Morris K.D., Carroll V., Bicknell R. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 2000, 141:995-1000.
94. Fraser H.M., Wulff C. Angiogenesis in the primate ovary. Reprod. Fertil. Dev. 2001, 13:557-566.
95. Gale N.W., Yancopoulos G.D. Growth factors acting via endothelial cell specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999, 13:1055-1066.
96. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
97. Dumont D.J., Gradwohl G., Fong G.H., Puri M.C., Gertsenstein M., Auerbach A., Breitman M.L. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994, 8:1897-1909.
98. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511-2514.
99. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., Glazer N., Holash J., McDonald D.M., Yancopoulos G.D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000, 6:460-463.
100. Papapetropoulos A., Garcia-Cardena G., Dengler T.J., Maisonpierre P.C., Yancopoulos G.D., Sessa W.C. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 1999, 79:213-223.
101. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994-1998.
102. Stratmann A., Risau W., Plate K.H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 1998, 153:1459-1466.
103. Visconti R.P., Richardson C.D., Sato T.N. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. USA 2002, 99:8219-8224.
104. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284:1994-1998.
105. Wiegand S.J., Boland P., Yancopoulos G.D. Cooperative roles of the angiopoietins and vascular endothelial growth factor in ovarian angiogenesis. Ovulation: Evolving Scientific and Clinical Concepts 2000, 175-186. Springer-Verlag, New York. E.Y. Adashi (Ed.).
106. Gospodarowicz D., Cheng J., Lui G.M., Baird A., Esch F., Bohlen P. Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 1985, 117:2383-2391.
107. Guthridge M., Bertolini J., Cowling J., Hearn M.T. Localization of bFGF mRNA in cyclic rat ovary, diethylstilbesterol primed rat ovary, and cultured rat granulosa cells. Growth Factors 1992, 7:15-25.
108. Yamamoto S., Konishi I., Nanbu K., Komatsu T., Mandai M., Kuroda H., Matsushita K., Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol. Endocrinol. 1997, 11:223-230.
109. Doraiswamy V., Knutson D.L., Grazul-Bilska A.T., Redmer D.A., Reynolds L.P. Fibroblast growth factor receptor (FGFR)-1 and -2 in the ovine corpus luteum throughout the estrous cycle. Growth Factors 1998, 16:125-135.
110. Gospodarowicz D., Massoglia S., Cheng J., Fujii D.K. Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries. J. Cell. Physiol. 1986, 127:121-136.
111. Grazul-Bilska A.T., Redmer D.A., Jablonka-Shariff A., Biondini M.E., Reynolds L.P. Proliferation and progesterone production of ovine luteal cells from several stages of the estrous cycle: Effects of fibroblast growth factors and luteinizing hormone. Can. J. Physiol. Pharmacol. 1995, 73:491-500.
112. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA 1998, 95:5672-5677.
113. Carr B.R., Sadler R.K., Rochelle D.B., Stalmach M.A., MacDonald P.C., Simpson E.R. Plasma lipoprotein regulation of progesterone biosynthesis by human corpus luteum tissue in organ culture. J. Clin. Endocrinol. Metab. 1981, 52:875-881.
114. Gwynne J.T., Strauss J.F. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr. Rev. 1982, 3:299-329.
115. Ishii T., Hasegawa T., Pai C-I, Yvgi-Ohana N., Timberg R., Zhao L., Majdic G., Chung B-C, Orly J., Parker K.L. The roles of circulating high-density lipoproteins and trophic hormones in the phenotype of knockout mice lacking the steroidogenic acute regulatory protein. Mol. Endocrinol. 2002, 16:2297-2309.
116. Rainey W.E., Rodgers R.J., Mason J.I. The role of bovine lipoproteins in the regulation of steroidogenesis and HMG-CoA reductase in bovine adrenocortical cells. Steroids 1992, 57:167-173.
117. Balasubramaniam S., Goldstein J.L., Faust J.R., Brunschede G.Y., Brown M.S. Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat. J. Biol. Chem. 1977, 252:1771-1779.
118. Andersen J.M., Dietschy J.M. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary and tests of the rat. J. Biol. Chem. 1978, 253:9024-9032.
119. Kovanen P.T., Schneider W.J., Hillman G.M., Goldstein J.L, Brown M.S. Separate mechanisms for the uptake of high and low density lipoproteins by mouse adrenal gland in vivo. J. Biol. Chem. 1979, 254:5498-5505.
120. Gwynne J.T., Hess B. The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. J. Biol. Chem. 1980, 255:10875-10883.
121. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 1996, 271:518-520.
122. Cao G., Zhao L., Stangl H., Hasegawa T., Richardson J.A., Parker K.L, Hobbs H.H. Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol. Endocrinol. 1999, 13:1460-1473.
123. Trigatti B., Rigotti A., Krieger M. The role of the high-density lipoprotein receptor SR-B1 in cholesterol metabolism. Curr. Opin. Lipidol. 2000, 11:123-131.
124. Glass C., Pittman R.C., Civen M., Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J. Biol. Chem. 1985, 260:744-750.
125. Glass C., Pittman R.C., Weinstein D.B., Steinberg D. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc. Natl. Acad. Sci. USA 1983, 80:5435-5439.
126. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA 1997, 94:12610-12615.
127. Plump A.S., Erickson S.K., Weng W., Partin J.S., Breslow J.L., Williams D.L. Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J. Clin. Invest. 1996, 97:2660-2671.
128. Azhar S., Khan I., Puryear T., Chen Y.D., Gibori G. Luteal cell 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol metabolism throughout pregnancy in the rat. Endocrinology 1988, 123:1495-1503.
129. Lopez D., Sanchez M.D., Shea-Eaton W., McLean M.P. Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A. Endocrinology 2002, 143:2155-2168.
130. 2α on the expression of luteal genes as revealed by rat cDNA expression array. Endocrinology 2001, 149:4158-4161.
131. Behrman H.R., Armstrong D.T. Cholesterol esterase stimulation by luteinizing hormone in luteinized rat ovaries. Endocrinology 1969, 85:474-480.
132. Leaver H.A., Boyd G.S. Action of gonadotrophic hormones on cholesterol side chain cleavage and cholesterol ester hydrolase in the ovary of the immature rat. J. Reprod. Fertil. 1981, 63:101-108.
133. Trzeciak W.H., Boyd G.S. Activation of cholesteryl esterase in bovine adrenal cortex. Eur. J. Biochem. 1974, 46:201-207.
134. Caffrey J.L., Fletcher P.W., Diekman M.A., O'Callaghan P.L., Niswender G.D. The activity of ovine luteal cholesterol esterase during several experimental conditions. Biol. Reprod. 1979, 21:601-608.
135. Behrman H.R., Orczyk G.P., Macdonald G.J., Greep R.O. Prolactin induction of enzymes controlling luteal cholesterol ester turnover. Endocrinology 1970, 87:1251-1256.
136. Klemcke H.G., Brinkley H.J. Effects of bromocriptine and PRL on luteal and adrenal cholesterol ester hydrolase and serum progesterone concentrations in mature pseudopregnant rats. Biol. Reprod. 1980, 22:1029-1039.
137. Aten R.F., Kolodecik T.R., Macdonald G.J., Behrman H.R. Modulation of cholesteryl esterase hydrolase messenger ribonucleic acid levels, protein levels, and activity in the rat corpus luteum. Biol. Reprod. 1995, 53:1110-1117.
138. Crivello J.F., Jefcoate C.R. Mechanisms of corticotropin action in rat adrenal cells. I. The effects of inhibitors of protein synthesis and of microfilament formation on corticosterone synthesis. Biochim. Biophys. Acta. 1978, 542:315-329.
139. Scallen T.J., Pastuszyn A., Nolan B.J., Chanderbhan R., Kharroubi A., Vahouny G.V. Sterol carrier and lipid transfer proteins. Chem. Phys. Lipids 1985, 38:239-261.
140. McLean M.P., Nelson S.E., Billheimer J.T., Gibori G. Differential capacity for cholesterol transport and processing in large and small rat luteal cells. Endocrinology 1992, 131:2203-2212.
141. McLean M.P., Puryear T.K., Khan I., Azhar S., Beillheimer J.T., Orly J., Gibori G. Estradiol regulation of sterol carrier protein 2 independent of cytochrome P450 side-chain cleavage expression in the rat corpus luteum. Endocrinology 1989, 125:1337-1344.
142. Tanaka T., Billheimer J.T., Strauss J.F. Luteinized rat ovaries contain a sterol carrier protein. Endocrinology 1984, 114:533-540.
143. Steinschneider A., McLean M.P., Billheimer J.T., Azhar S., Gibori G. Protein kinase C catalyzed phosphorylation of sterol carrier protein 2. Endocrinology 1989, 125:569-571.
144. Leung P.C.K., Minegishi T., Wang J. Inhibition of FSH and cyclic adenosine-3',5'-monophosphate induced progesterone production by calcium and protein kinase C in the rat ovary. Am. J. Obstet. Gynecol. 1988, 158:350-356.
145. 2α in isolated rat luteal cells. Endocrinology 1987, 120:1019-1026.
146. Wiltbank M.C., Knickerbocker J.J., Niswender G.D. Regulation of the corpus luteum by protein kinase C. I. Phosphorylation activity and steroidogenic action in large and small ovine luteal cells. Biol. Reprod. 1989, 40:1194-1200.
147. Niswender G.D. Molecular control of luteal secretion of progesterone. Reproduction 2002, 123:333-339.
148. Christenson L.K., Strauss J.F. Steroidogenic acute regulatory protein: An update on its regulation and mechanism of action. Arch. Med. Res. 2001, 32:576-586.
149. Clark B.J., Wells J., King S.R., Stocco D.M. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 1994, 269:28314-28322.
150. Stocco D.M. Steroidogenic acute regulatory protein. Vitam. Horm. 1999, 55:399-441.
151. Stocco D.M., Clark B.J. Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 1996, 17:221-244.
152. Clark B.J., Soo S.C., Caron K.M., Ikeda Y., Parker K.L., Stocco D.M. Hormonal and developmental regulation of the sterodogenic acute regulatory protein. Mol. Endocrinol. 1995, 9:1346-1355.
153. Caron K.M., Soo S.C., Wetsel W.C., Stocco D.M., Clark B.J., Parker K.L. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc. Natl. Acad. Sci. USA 1997, 94:11540-11545.
154. Bose H.S., Lingappa V.R., Miller W.L. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 2002, 417:87-91.
155. West A., Horvat R.D., Roess D.A., Barisas B.G., Juengel J.L., Niswender G.D. Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology 2001, 142:502-505.
156. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr. Rev. 1993, 14:222-240.
157. Arakane F., Kallen C.B., Watari H., Stayrook S.E., Lewis M., Strauss J.F. Steroidogenic acute regulatory protein (StAR) acts on the outside of mitochondria to stimulate steroidogenesis. Endocr. Rev. 1998, 24:463-468.
158. Kallen C.B., Billheimer J.T., Summers S.A., Stayrook S.E., Lewis M., Strauss J.F. Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein. J. Biol. Chem. 1998, 273:26285-26288.
159. Christinsen K., Bose H.S., Harris F.M., Miller W.L., Bell J.D. Binding of steroidogenic acute regulatory protein to synthetic membranes suggests an active molten globule. J. Biol. Chem. 2001, 276:17044-17051.
160. Bose H.S., Baldwin M.A., Miller W.L. Evidence that StAR and MLN64 act on the outer mitochondrial membrane as molten globules. Endocr. Res. 2000, 26:629-637.
161. Ponting C.P., Aravind L. START: A lipidbinding domain in StAR, HD-ZIP and signaling proteins. Trends Biochem. Sci. 1999, 24:130-132.
162. Tsujishita Y., Hurley J.H. Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 2000, 7:408-414.
163. Petrescu A.D., Gallegos A.M., Okamura Y., Strauss J.F., Shroeder F. Steroidogenic acute regulatory protein binds cholesterol and modulates mitochondrial membrane sterol domain dynamics. J. Biol. Chem. 2001, 276:36970-36982.
164. Stocco D.M. Tracking the role of a StAR in the sky of the new millennium. Mol. Endocrinol. 2001, 15:1245-1254.
165. Oonk R.B., Krasnow J.S., Beattie W.G., Richards J.S. Cyclic AMP-dependent and -independent regulation of cholesterol side chain cleavage cytochrome P450 in rat ovarian granulosa cells and corpora lutea. J. Biol. Chem. 1989, 264:21934-21942.
166. Martel C., Gagne D., Couet J., Labrie Y., Simard J., Labrie F. Rapid modulation of ovarian 3-β-hydroxysteroid dehydrogenase/δ5-δ4 isomerase gene expression by prolactin and human chorionic gonadotropin in the hypophysectomized rat. Mol. Cell. Endocrinol. 1994, 99:63-71.
167. Jone P.B., Valk C.A., Hsueh A.J. Regulation of progestin biosynthetic enzymes in cultured rat granulosa cells: Effects of prolactin, beta 2-adrenergic agonist, human chorionic gonadotropin and gonadotropin releasing hormone. Biol. Reprod. 1983, 29:572-585.
168. Hickey G.J., Oonk R.B., Hall P.F., Richards J.S. Aromatase cytochrome P450 and cholesterol side-chain cleavage cytochrome P450 in corpora lutea of pregnant rats: Diverse regulation by peptide and steroid hormones. Endocrinology 1989, 125:1673-1682.
169. Akinola L.A., Poutanen M., Vihko R., Vihko P. Expression of 17β-hydroxysteroid dehydrogenase type 1 and type 2, P450 aromatase, and 20α-hydroxysteroid dehydrogenase enzymes in immature, mature, and pregnant rats. Endocrinology 1997, 138:2886-2892.
170. Nokelainen P., Peltoketo H., Vihko R., Vihko P. Expression cloning of a novel estrogenic mouse 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol. Endocrinol. 1998, 12:1048-1059.
171. Risk M., Duan W.R., Nelson S., Azhar S., Gibori G. Characterization of PRAP as a novel 17β-hydroxysteroid dehydrogenase (17βHSD) enzyme. Biol. Reprod. Suppl 1999, 60(1):162. Abstract #221.
172. Pelletier G., Luu-The V., Tetu B., Labrie F. Immunocytochemical localization of type 5 17β-hydroxysteroid dehydrogenase in human reproductive tissues. J. Histochem. Cytochem. 1999, 47:731-738.
173. Zhang Y., Word R.A., Fesmire S., Carr B.R., Rainey W.E. Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3. J. Clin. Endocrinol. Metab. 1996, 81:3594-3598.
174. 17α activity in corpora lutea and follicles. Endocrinology 1987, 121:1312-1319.
175. Bogovich K., Richards J.S., Reichert L.E. Obligatory role of luteinizing hormone (LH) in the initiation of preovulatory follicular growth in the pregnant rat: Specific effects of human chorionic gonadotropin and follicle-stimulating hormone on LH receptors and steroidogenesis in theca, granulosa, and luteal cells. Endocrinology 1981, 109:860-867.
176. 17-20 lyase activities. Endocrinology 1982, 111:1201-1208.
177. Morishige W.K., Pepe G.J., Rothchild I. Serum luteinizing hormone, PRL, and progesterone levels during pregnancy in the rat. Endocrinology 1973, 92:1527-1530.
178. Gibori G., Khan I., Warshaw M.L., McLean M.P., Puryear T.K., Nelson S., Durkee T.J., Azhar S., Steinschneider A., Rao M.C. Placental derived regulators and the complex control of luteal cell function. Rec. Prog. Hormone Res. 1988, 44:377-429.
179. Gibori G., Sridaran R., Basuray R. Control of aromatase activity in luteal and ovarian nonluteal tissue of pregnant rats. Endocrinology 1982, 111:781-788.
180. Lephart E.D., Simpson E.R., McPhaul M.J. Ovarian aromatase cytochrome P450 mRNA levels corre-late with enzyme activity and serum estradiol levels in anestrous, pregnant and lactating rats. Mol. Cell. Endocrinol. 1992, 85:205-214.
181. Krasnow J.S., Hickey G.J., Richards J.S. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by PRL. Mol. Endocrinol. 1990, 4:13-21.
182. Shaikh A.A. Estrone and estradiol levels in the ovarian venous blood from rats during the estrous cycle and pregnancy. Biol. Reprod. 1971, 5:297-307.
183. Ghersevich S.A., Poutanen M.H., Rajaniemi H.J., Vihko R.K. Expression of 17β-hydroxysteroid dehydrogenase in the rat ovary during follicular development and luteinization induced with pregnant mare serum gonadotrophin and human chorionic gonadotrophin. J. Endocrinol. 1994, 140:409-417.
184. Nokelainen P., Puranen T., Peltoketo H., Orava M., Vihko P., Vihko R. Molecular cloning of mouse 17β-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. Eur. J. Biochem. 1996, 236:482-490.
185. Parmer T.G., McLean M.P., Duan W.R., Nelson S.E., Albarracin C.T., Khan I., Gibori G. Hormonal and immunological characterization of the 32 kilodalton ovarian-specific protein. Endocrinology 1992, 131:2213-2221.
186. Nokelainen P., Peltoketo H., Mustonen M., Vihko P. Expression of mouse 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase type 7 in the ovary, uterus, and placenta: Localization from implantation to late pregnancy. Endocrinology 2000, 141:772-778.
187. 17α and PRAP/17β-HSD expression in the rat corpus luteum leads to differential expression of these genes throughout pregnancy. Biol. Reprod. Suppl. 1999, 60(1):154. Abstract #195.
188. McLean M.P., Nelson S., Parmer T., Khan I., Steinschneider A., Puryear T., Gibori G. Identification and characterization of an abundant phosphoprotein specific to the large luteal cell. Endocrinology 1990, 126:1796-1805.
189. Duan W.R., Parmer T.G., Albarracin C.T., Zhong L., Gibori G. PRAP, a prolactin receptor associated protein: Its gene expression and regulation in the corpus luteum. Endocrinology 1997, 138:3216-3221.
190. Duan W.R., Linzer D.I.H., Gibori G. Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J. Biol. Chem. 1996, 271:15602-15607.
191. Albarracin C.T., Parmer T.G., Duan W.R., Nelson S.E., Gibori G. Identification of a major PRL-regulated protein as 20α-hydroxysteroid dehydrogenase: Coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 1994, 134:2453-2460.
192. Zhong L., Parmer T.G., Robertson M.C., Gibori G. PRL-mediated inhibition of 20α-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Biochem. Biophys. Res. Commun. 1997, 235:587-592.
193. Albarracin C.T., Gibori G. PRL action on luteal protein expression in the corpus luteum. Endocrinology 1991, 129:1821-1830.
194. Lamprecht S.A., Lindner H.R., Strauss J.F. Induction of 20 alpha hydroxysteroid dehydrogenase in rat corpora lutea by pharmacological blockade of pituitary PRL secretion. Biochim. Biophys. Acta. 1969, 187:133-143.
195. Wiest W.G., Kidwell W.R., Bologh K. Progesterone catabolism in the rat ovary: A regulatory mechanism for progestational potency during pregnancy. Endocrinology 1968, 82:844-852.
196. Yoshida S., Kubota K., Sasaki H., Hasegawa T., Nishihara M., Terada M., Takahashi M. 26-cholesterol hydroxylase in rat corpora lutea: A negative regulator of progesterone secretion. Biol. Reprod. 1999, 61:557-562.
197. Sridaran R., Gibori G. Dihydrotestosterone secretion in pregnant and pseudopregnant rats. Proc. Soc. Biol. Med. 1989, 192:281-284.
198. Sridaran R., Gibori G. Induction of luteolysis by dihydrotestosterone in the pregnant rat. Am. J. Physiol. 1981, 241:E444-E448.
199. Mahendroo M.S., Porter A., Russell D.W., Word R.A. The parturition defect in steroid 5α-reductase type 1 knockout mice is due to impaired cervical ripening. Mol. Endocrinol. 1999, 13:981-992.
200. Nelson S.E., McLean M.P., Jayatilak P.G., Gibori G. Isolation, characterization and culture of cell subpopulations forming the pregnant rat corpus luteum. Endocrinology 1992, 130:954-966.
201. Girsh E., Greber Y., Meidan R. Luteotropic and luteolytic interactions between bovine small and large luteal-like cells and endothelial cells. Biol. Reprod. 1995, 52:954-962.
202. Christenson L.K., Stouffer R.L. Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. Endocrinology 1996, 137:367-374.
203. Suzuki T., Sasano H., Takaya R., Fukaya T., Yajima A., Nagura H. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum. Reprod. 1998, 13:953-959.
204. Gaytan F., Morales C., Garcia-Pardo L., Reymundo C., Bellido C., Sanchez-Criado J.E. A quantitative study of changes in the human corpus luteum microvasculature during the menstrual cycle. Biol. Reprod. 1999, 60:914-919.
205. Gillim S.W., Christensen A.K., McLennan C.F. Fine structure of the human menstrual corpus luteum at its stage of maximum secretory activity. Am. J. Anat. 1969, 126:409-415.
206. Petrovska M., Dimitrov D.G., Michael S.D. quantitative changes in macrophage distribution in normal mouse ovary over the course of the estrous cycle examined with an image analysis system. Am. J. Reprod. Immunol. 1996, 36:175-183.
207. Bukovsky A., Caudle M.R., Keenan J.A., Wimalasena J., Upadhyaya N.B., Van Meter S.E. Is corpus luteum regression an immune-mediated event? Localization of immune system components and luteinizing hormone receptor in human corpora lutea. Biol. Reprod. 1995, 53:1373-1384.
208. Brannstrom M., Mayrhofer G., Robertson S.A. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol. Reprod. 1993, 48:277-286.
209. Brannstrom M., Pascoe V., Norman R.J., McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil. Steril. 1994, 61:488-495.
210. Brannstrom M., Giesecke L., Moore I.C., van den Heuvel C.J., Robertson S.A. Leukocyte subpopulations in the rat corpus luteum during pregnancy and pseudopregnancy. Biol. Reprod. 1994, 50:1161-1167.
211. Smith M.F., McIntush E.W., Smith G.W. Mechanisms associated with corpus luteum development. J. An. Sci. 1994, 72:1857-1872.
212. Murdoch W.J., McCormick R.J. Mechanisms and physiological implications of leucocyte chemoattraction into periovulatory ovine follicles. J. Reprod. Fertil. 1993, 97:375-380.
213. Presl J., Bukovsky A. Role of Thy-1+ and Ia+ cells in ovarian function. Biol. Reprod. 1986, 34:159-169.
214. Pate J.L., Keyes P.L. Immune cells in the corpus luteum: Friends or foes?. Reproduction 2001, 122:665-676.
215. Lobel B.L., Levy E. Enzymatic correlates of development, secretory function and regression of follicles and corpora lutea in the bovine ovary. II. Formation, development and involution of corpora lutea. Acta. Endocrinol. (Copenh.) Suppl. 1968, 132:5-63.
216. Niswender G.D., Juengel J.L., Silva P.J., Rollyson M.K., McIntush E.W. Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev. 2000, 80:1-29.
217. Nelson S.E., Gibori G., Hunzicker-Dunn M. The cap-dependent signaling cascade in the two luteal cell types of the pregnant rat corpus luteum. Mol. Cell. Endocrinol. 1992, 85:195-203.
218. Niswender G.D., Juengel J.L., McGuire W.J., Belfiore C.J., Wiltbank M.C. Luteal function: The estrous cycle and early pregnancy. Biol. Reprod. 1994, 50:239-247.
219. Ohara A., Mori T., Taii S., Ban C., Narimoto K. Functional differentiation in steroidogenesis of two types of luteal cells isolated from mature human corpora lutea of menstrual cycle. J. Clin. Endocrinol. Metab. 1987, 65:1192-1200.
220. Retamales I., Carrasco I., Troncoso J.L., Las Heras J., Devoto L., Vega M. Morpho-functional study of human luteal cell subpopulations. Hum. Reprod. 1994, 9:591-596.
221. Sanders S.L., Stouffer R.L. Localization of steroidogenic enzymes in macaque luteal tissue during the menstrual cycle and simulated early pregnancy: Immuno-histochemical evidence supporting the two-cell model for estrogen production in the primate corpus luteum. Biol. Reprod. 1997, 56:1077-1087.
222. Sanders S.L., Stouffer R.L., Brannian J.D. Androgen production by monkey luteal cell subpopulations at different stages of the menstrual cycle. J. Clin. Endocrinol. Metab. 1996, 81:591-596.
223. Grazul-Bilska A.T., Redmer D.A., Reynolds L.P. Cellular interactions in the corpus luteum. Sem. Reprod. Endocrinol. 1997, 15:383-393.
224. Porter D.J., Finn C.A. The biology of the uterus. Frontiers in Reproduction and Fertility Control 1997, 132-145. MIT Press, Cambridge, Mass. R.O. Greep, M.A. Koblinsky (Eds.).
225. Freeman M.E. The neuroendocrine control of the ovarian cycle in the rat. The Physiology of Reproduction 1994, Vol. 2:613-658. Raven Press, New York. 2d ed. E. Knobil, J.D. Neill (Eds.).
226. Butcher R.L., Fugo N.W., Collins W.C. Semicircadian rhythm in plasma levels of PRL during early gestation in the rat. Endocrinology 1972, 90:1125-1127.
227. Freeman M.E., Neill J.D. The pattern of PRL secretion during pseudopregnancy in the rat: A daily nocturnal surge. Endocrinology 1972, 90:1292-1298.
228. Kraicer P.F., Shelesnyak M.C. Studies on the mechanism of nidation. IX. Analysis of the response to ergocornine, an inhibitor of nidation. J. Reprod. Fertil. 1964, 8:225-233.
229. Telleria C.M., Zhong L., Deb S., Srivastava R.K., Park K.S., Sugino N., Park-Sarge O.K., Gibori G. Differential expression of the estrogen receptors α and β in the rat corpus luteum of pregnancy: Regulation by PRL and placental lactogens. Endocrinology 1998, 139:2432-2442.
230. Frasor J., Park K., Byers M., Telleria C., Kitamura T., Yu-Lee L.Y., Djiane J., Park-Sarge O.K., Gibori G. Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERα and ERβ transcription. Mol. Endocrinol. 2001, 15:2172-2181.
231. Gibori G., Keyes P.L. Luteotropic role of estrogen in early pregnancy in the rat. Endocrinology 1980, 106:1584-1588.
232. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the PRL gene. EMBO J. 1997, 16:6926-6935.
233. Ormandy C.J., Camus A., Barra J., Damotte D., Lucas B., Buteau H., Edery M., Brousse N., Babinet C., Binart N., Kelly P.A. Null mutation of the PRL receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 1997, 11:167-168.
234. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
235. Binart N., Helloco C., Ormandy C.J., Barra J., Clement-Lacroix P., Baran N., Kelly P.A. Rescue of preimplantatory egg development and embryo implantation in PRL receptor-deficient mice after progesterone administration. Endocrinology 2000, 141:2691-2697.
236. Reese J., Binart N., Brown N., Ma W.G., Paria B.C., Das S.K., Kelly P.A., Dey S.K. Implantation and decidualization defects in PRL receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 2000, 141:1872-1881.
237. Morishige W.K., Rothchild I. Temporal aspects of the regulation of corpus luteum function by luteinizing hormone, PRL and placental luteotrophin during the first half of pregnancy in the rat. Endocrinology 1974, 95:260-274.
238. Jayatilak P.G., Puryear T.K., Herz Z., Fazleabas A., Gibori G. Protein secretion by mesometrial and antimesometrial decidual tissue: Evidence for differential gene expression. Endocrinology 1989, 125:659-666.
239. Jayatilak P.G., Glaser L.A., Basuray R., Kelly P.A., Gibori G. Identification and partial characterization of a PRL-like hormone produced by the rat decidual tissue. Proc. Natl. Acad. Sci. USA 1985, 82:217-221.
240. Gibori G., Rothchild I., Pepe G.J., Morishige W.K., Lam P. Luteotropic action of decidual tissue in the rat. Endocrinology 1974, 95:1113-1118.
241. Basuray R., Gibori G. Luteotropic action of decidual tissue in the pregnant rat. Biol. Reprod. 1980, 23:507-512.
242. Jayatilak P.G., Gibori G. Ontogeny of PRL receptors in rat decidual tissue: Binding by a locally produced PRL-like hormone. J. Endocrinol. 1986, 110:115-121.
243. Herz Z., Khan I., Jayatilak P.G., Gibori G. Evidence for the synthesis and secretion of decidual luteotropin: A PRL-like hormone produced by rat decidual cells. Endocrinology 1986, 118:2203-2209.
244. Prigent-Tessier A., Tessier C., Hirosawa-Takamori M., Boyer C., Ferguson-Gottschall S., Gibori G. Rat decidual PRL: Identification, molecular cloning, and characterization. J. Biol. Chem. 1999, 274:37982-37989.
245. Jabbour H.N., Critchley H.O.D. Potential roles of decidual prolactin in early pregnancy. Reproduction 2001, 121:197-205.
246. Gu Y., Srivastava R.K., Clarke D.L., Linzer D.I.H., Gibori G. The decidual PRL receptor and its regulation by decidua-derived factors. Endocrinology 1996, 137:4878-4885.
247. Jayatilak P.G., Glaser L.A., Warshaw M.L., Herz Z., Gruber J.R., Gibori G. Relationship between LH and decidual luteotropin in the maintenance of luteal steroidogenesis. Biol. Reprod. 1984, 31:556-564.
248. Gibori G., Basuray R., McReynolds B. Luteotropic role of the decidual tissue in the rat: Dependency on intraluteal estradiol. Endocrinology 1981, 108:2060-2066.
249. Gibori G., Rodway R., Rothchild I. The luteotropic effect of estradiol in the rat: Prevention by estradiol of the luteolytic effect of an antiserum of LH in the pregnant rat. Endocrinology 1977, 101:1683-1689.
250. Gibori G., Keyes P.L., Richards J.S. A role for intraluteal estrogen in the mediation of LH action on the rat corpus luteum during pregnancy. Endocrinology 1978, 103:162-169.
251. Keyes P.L., Gibori G., Possley R.R., Brown J.M. Early changes in luteal function associated with the luteotropic effect of testosterone in the pregnant rat. Biol. Reprod. 1980, 22:1142-1148.
252. Armstrong D.T., Miller L.V., Knudsen K.A. Regulation of lipid metabolism and progesterone production in rat corpora lutea and ovarian interstitial elements by PRL and luteinizing hormone. Endocrinology 1969, 85:393-401.
253. Segaloff D., Wang H.Y., Richards J.S. Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol. Endocrinol. 1990, 4:1856-1865.
254. Gafvels M., Bjurulf E., Selstam G. PRL stimulates the expression of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid in the rat corpus luteum and rescues early pregnancy from bromocriptine-induced abortion. Biol. Reprod. 1992, 47:534-540.
255. Bjurulf E., Selstam G., Olofsson J.I. Increased LH receptor mRNA and extended corpus luteum function induced by PRL and indomethacin treatment in vivo in hysterectomized pseudopregnant rats. J. Reprod. Fertil. 1994, 102:139-145.
256. Gibori G., Richards J.S., Keyes P.L. Synergistic effects of PRL and estradiol in the luteotropic process in the pregnant rat: Regulation of estradiol receptor by PRL. Biol. Reprod. 1979, 21:419-423.
257. Frasor J., Barkai U., Zhong L., Fazleabas A.T., Gibori G. PRL-induced ERα gene expression is mediated by janus kinase (Jak 2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves jak2 and a second tyrosine kinase. Mol. Endocrinol. 2001, 15:1941-1952.
258. Pencharz R.I., Long J.A. The effect of hypophysectomy on gestation in the rat. Science 1931, 74:206.
259. Faria T.N., Deb S., Kwok S.C.M., Talamantes F., Soares M.J. Ontogeny of placental lactogen-I and placental lactogen-II expression in the developing rat placenta. Dev. Biol. 1990, 141:279-291.
260. Ogren L., Talamantes F. Prolactins of pregnancy and their cellular source. Intl. Rev. Cytol. 1988, 112:1-65.
261. Soares M.J., Faria T.N., Roby K.F., Deb S. Pregnancy and the PRL family of hormones: Coordination of anterior pituitary, uterine, and placental expression. Endocr. Rev. 1991, 12:402-423.
262. Glaser L.A., Khan I., Pepe G.J., Kelly P.A., Gibori G. Further studies on rat placental lactogens. Prolactin: Basic and Clinical Correlates 1985, Vol. I:495-499. Section VII, Fidia Research Series, Livania Press, Padova. R.M. MacLeod, M.O. Thorner, U. Scapagnini (Eds.).
263. Kelly P.A., Shiu R.P.C., Robertson M.C., Friesen H.G. Characterization of rat chorionic mammotropin. Endocrinology 1975, 96:1187-1195.
264. Glaser L.A., Kelly P.A., Gibori G. Differential action and secretion of rat placental lactogens. Endocrinology 1984, 115:969-976.
265. Sugino N., Hirosawa-Takamori M., Zhong L., Telleria C.M., Shiota K., Gibori G. Hormonal regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase in the rat corpus luteum: Induction by PRL and placental lactogens. Biol. Reprod. 1998, 59:599-605.
266. Peters C.A., Maizels E.T., Robertson M.C., Shiu R.P.C., Soloff M.S., Hunzicker-Dunn M. Induction of relaxin messenger RNA expression in response to prolactin receptor activation requires protein kinase C δ signaling. Mol. Endocrinol. 2000, 14:576-590.
267. Tessier C., Deb S., Prigent-Tessier A., Ferguson-Gottschall S., Gibori G.B., Shiu R.P.C., Gibori G. Estrogen receptors α and β in rat decidua cells: Cell-specific expression and differential regulation by steroid hormones and prolactin. Endocrinology 2000, 141:3842-3851.
268. Tessier C., Prigent-Tessier A., Ferguson-Gottschall S., Gu Y., Gibori G. PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 2001, 142:4086-4094.
269. MacLeod K.R., Smith W.C., Ogren L., Talamantes F. Recombinant mouse placental lactogen-I binds to lactogen receptors in mouse liver and ovary: Partial characterization of the ovarian receptor. Endocrinology 1989, 125:2258-2266.
270. Galosy S.S., Talamantes F. Luteotropic actions of placental lactogens at midpregnancy in the mouse. Endocrinology 1995, 136:3993-4003.
271. Thordarson G., Galosy S., Gudmundsson G.O., Newcomer B., Sridaran R., Talamantes F. Interaction of mouse placental lactogens and androgens in regulation progesterone release in cultured mouse luteal cells. Endocrinology 1997, 138:3236-3241.
272. Pinon I., Kishi K., Talamantes F. The kinetics of disappearance of endogenous mouse placental lactogen-II in intact and hypophysectomized pregnant mice. Mol. Cell. Endocrinol. 1988, 55:45-51.
273. Gibori G., Chatterton R.T., Chien J.L. Ovarian and serum concentrations of androgen throughout pregnancy in the rat. Biol. Reprod. 1979, 21:53-56.
274. scc gene expression and regulation in the rat trophoblast. Endocrinology 1992, 130:1309-1317.
275. Warshaw M.L., Johnson D.C., Khan I., Eckstein B., Gibori G. Placental secretion of androgens in the rat. Endocrinology 1986, 119:2642-2648.
276. Jackson J.A., Albrecht E.D. The development of placental androstenedione and testosterone production and their utilization by the ovary for aromatization to estrogen during rat pregnancy. Biol. Reprod. 1985, 33:451-457.
277. Warshaw M.L., Johnson D.C., Azhar S., Gibori G. Opposite effect of human chorionic gonadotropin in placental and ovarian synthesis of androstenedione. Endocrinology 1987, 120:2003-2010.
278. Gunnersen J.M., Crawford R.J., Tregear G.W. Expression of the relaxin gene in rat tissues. Mol. Cell. Endocrinol. 1995, 110:55-64.
279. Lao Guico-Lamm M., Sherwood O.D. Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats. Endocrinology 1988, 123:2479-2485.
280. Hwang J.J., Sherwood O.D. Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats. Endocrinology 1988, 123:2486-2490.
281. Zhao L., Roche P.J., Gunnersen J.M., Hammond V.E., Tregear G.W., Wintour E.M., Beck F. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 1999, 140:445-453.
282. Risk M., Gibori G. Mechanisms of luteal cell regulation by prolactin. Prolactin 2001, 265-295. Kluwer Academic Publishers, Boston. N.D. Horseman (Ed.).
283. Prigent-Tessier A., Barkai U., Tessier C., Cohen H., Gibori G. Characterization of a rat uterine cell line, UIII cells: Prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; Estrogen receptor β, α2-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Endocrinology 2001, 142:1242-1250.
284. Deb S., Tessier C., Prigent-Tessier A., Barkai U., Ferguson-Gottschall S., Srivastava R.K., Faliszek J., Gibori G. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: Regulation by 17β-estradiol and prolactin. Endocrinology 1999, 140:4442-4450.
285. Liu X., Robinson G.W., Wagner K.U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactatogenesis. Genes Dev. 1997, 11:179-186.
286. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., Waxman D.J., Davey H.W. Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 1997, 94:7239-7244.
287. Peters C.A., Maizels E.T., Hunzicker-Dunn M. Activation of PKCδ in the rat corpus luteum during pregnancy: Potential role of prolactin signaling. J. Biol. Chem. 1999, 274:37499-37505.
288. Zarrow M.X., Clark J.H. Gonadotropin regulation of ovarian cholesterol levels in the rat. Endocrinology 1969, 84:340-346.
289. Armstrong D.T., Knudsen K.A., Miller L.S. Effects of prolactin upon cholesterol metabolism and progesterone biosynthesis in corpora lutea of rats hypophysectomized during pseudopregnancy. Endocrinology 1970, 86:634-641.
290. Rajkumar K., Couture R.L., Murphy B.D. Binding of high-density lipoproteins to luteal membranes: The role of prolactin, luteinizing hormone, and circulating lipoproteins. Biol. Reprod. 1985, 32:546-555.
291. Menon M., Peegel H., Menon K.M. Lipoprotein augmentation of human chorionic gonadotropin and prolactin stimulated progesterone synthesis by rat luteal cells. J. Steroid. Biochem. 1985, 22:79-84.
292. Albarracin C.T., Palfrey H.C., Duan W.R., Rao M.C., Gibori G. PRL regulation of the calmodulin-dependent protein kinase III elongation factor-2 system in the rat corpus luteum. J. Biol. Chem. 1994, 269:7772-7776.
293. Sugino N., Telleria C.M., Tessier C., Gibori G. Regulation and role of the insulin-like growth factor I system in rat luteal cells. J. Reprod. Fertil. 1999, 115:349-355.
294. LeRoith D., Werner H., Beitner-Johnson D., Roberts C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 1995, 16:143-163.
295. Zhou J., Chin E., Bondy C. Cellular pattern of insulin-like growth factor-I (IGF-1) and IGF-1 receptor gene expression in the developing and mature ovarian follicle. Endocrinology 1991, 129:3281-3288.
296. Parmer T.G., Roberts C.T., LeRoith D., Adashi E.Y., Khan I., Solan N., Nelson S., Zilberstein M., Gibori G. Expression, action, and steroidal regulation of insulin-like growth factor-I (IGF-1) and IGF-1 receptor in the rat corpus luteum: Their differential role in the two cell populations forming the corpus luteum. Endocrinology 1991, 129:2924-2932.
297. Talavera F., Menon K.M.J. Studies on rat luteal cell response to insulin-like growth factor-1 (IGF-1): Identification of a specific cell membrane receptor for IGF-1 in the luteinized rat ovary. Endocrinology 1991, 129:1340-1346.
298. Corbacho A.M., Martinez de la Escalera G., Clapp C. Roles of PRL and related members of the PRL/growth hormone/placental lactogen family in angiogenesis. J. Endocrinol. 2002, 173:219-238.
299. Dennis P.A., Sarsela O., Harpel P., Rifkin D.B. Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. J. Biol. Chem. 1989, 264:7210-7216.
300. da Silva G.C., Teixeira N.J., Bell S.C. Major secretory product of the mesometrial decidua in the rat, a variant of alpha-2-macroglobulin, binds insulin-like growth factor I via a protease-dependent mechanism. Mol. Reprod. Dev. 1996, 44:103-110.
301. Ji T.H., Ryu K.S., Gilchrist R., Ji I. Interaction, signal generation, signal divergence, and signal transduction of LH/CG and the receptor. Rec. Prog. Hormone Res. 1997, 52:431-453.
302. Chen Z., Menon K.M.J. Expression of high density lipoprotein-binding protein messenger ribonucleic acid in the rat ovary and its regulation by gonadotropin. Endocrinology 1994, 134:2360-2366.
303. Zeleznik A.J., Benyo D.F. Control of follicular development, corpus luteum function, and the recognition of pregnancy in higher primates. The Physiology of Reproduction 1994, Vol. 2:751-782. Raven Press, New York. 2d ed. E. Knobil, J.D. Neill (Eds.).
304. Ravindranath N., Little-Ihrig L.L., Benyo D.F., Zeleznik A.J. Role of luteinizing hormone in the expression of cholesterol side-chain cleavage cytochrome P450 and 3β-hydroxysteroid dehydrogenase, delta 4-5 isomerase messenger ribonucleic acids in the primate corpus luteum. Endocrinology 1992, 131:2065-2070.
305. Duncan W.C., Cowen G.M., Illingworth P.J. Steroidogenic enzyme expression in human corpora lutea in the presence and absence of exogenous human chorionic gonadotrophin (HCG). Mol. Hum. Reprod. 1999, 5:291-298.
306. Devoto L., Kohen P., Vega M., Castro O., Gonzalez R.R., Retamales I., Carvallo P., Christenson L.K., Strauss J.F. Control of human luteal steroidogenesis. Mol. Cell. Endocrinol. 2002, 186:137-141.
307. Reinhart A.J., Williams S.C., Stocco D.M. Transcriptional regulation of the StAR gene. Mol. Cell. Endocrinol. 1999, 151:161-169.
308. Shea-Eaton W., Sandhoff T.W., Lopez D., Hales D.B., McLean M.P. Transcriptional repression of the rat steroidogenic acute regulatory (StAR) protein gene by the AP-1 family member c-Fos. Mol. Cell. Endocrinol. 2002, 188:161-170.
309. Nackley A.C., Shea-Eaton W., Lopez D., McLean M.P. Repression of the steroidogenic acute regulatory gene by the multifunctional transcription factor Yin Yang 1. Endocrinology 2002, 143:1085-1096.
310. Sandhoff T.W., Hales D.B., Hales K.H., McLean M.P. Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor I. Endocrinology 1998, 139:4820-4831.
311. Granot Z., Silverman E., Friedlander R., Melamed-Book N., Eimerl S., Timberg R., Hales K.H., Hales D.B., Stocco D.M., Orly J. The life cycle of the steroidogenic acute regulatory (StAR) protein: From transcription through proteolysis. Endocr. Res. 2002, 28:375-386.
312. 2α is modulated by the negative transcription factor DAX-1. Endocrine 1999, 10:83-91.
313. Ghosh D.K., Menon K.M. Induction of high-density lipoprotein receptors in rat corpus luteum by human choriogonadotropin. Evidence of protein synthesis de novo. Biochem. J. 1987, 244:471-479.
314. Li X., Peegel H., Menon K.M. In situ hybridization of high density lipoprotein (scavenger, type 1) receptor messenger ribonucleic acid (mRNA) during folliculogenesis and luteinization: Evidence for mRNA expression and induction by human chorionic gonadotropin specifically in cell types that use cholesterol for steroidogenesis. Endocrinology 1998, 139:3043-3049.
315. 125I] low density lipoprotein uptake and metabolism by luteinized human granulosa cells in culture. J. Clin. Endocrinol. Metab. 1985, 61:633-638.
316. Murphy B.D., Rajkumar K., McKibbin P.E., Macdonald G.J., Buhr M.M., Grinwich D.L. The effects of hypophysectomy and administration of pituitary hormones on luteal function and uptake of high density lipoproteins by luteinized ovaries and adrenals of the rat. Endocrinology 1985, 116:1587-1597.
317. Hull K.L., Harvey S. Growth hormone: Roles in female reproduction. J. Endocrinol. 2001, 168:1-23.
318. Schams D., Koll R., Li C.H. Insulin-like growth factor-1 stimulates oxytocin and progesterone production by bovine granulosa cells in culture. J. Endocrinol. 1988, 116:97-100.
319. Constantino C.X., Keyes P.L., Kostyo J.L. Insulin-like growth factor-1 stimulates steroidogenesis in rabbit luteal cells. Endocrinology 1991, 128:1702-1708.
320. McArdle C.A., Holtorf A.-P. Oxytocin and progesterone release from bovine corpus luteal cells in culture: Effects of insulin-like growth factor I, insulin and prostaglandins. Endocrinology 1989, 124:1278-1286.
321. Khan-Dawood F.S., Gargiulo A.R., Dawood M.Y. In vitro microdialysis of the ovine corpus luteum of pregnancy: Effects of insulin-like growth factor on progesterone secretion. Biol. Reprod. 1994, 51:1299-1306.
322. Devoto L., Christenson L.K., McAllister J.M., Makrigiannakis A., Strauss J.F. Insulin and insulin-like growth factor-I and II modulate human granulosa-lutein cell steroidogenesis: Enhancement of steroidogenic acute regulatory protein (StAR) expression. Mol. Hum. Reprod. 1999, 5:1003-1010.
323. Devoto L., Kohen P., Castro O., Vega M., Troncoso J.L., Charreau E. Multihormonal regulation of progesterone synthesis in cultured human midluteal cells. J. Clin. Endocrinol. Metab. 1995, 80:1566-1570.
324. Rothchild I. Regulation of the mammalian corpus luteum. Rec. Prog. Hormone Res. 1981, 37:183-298.
325. Duffy D.M., Hess D.L., Stouffer R.L. Acute administration of a 3β-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: Evidence for possible autocrine regulation of the primate corpus luteum by progesterone. J. Clin. Endocrinol. Metab. 1994, 79:1587-1594.
326. Telleria C.M., Deis R.P. Effect of RU486 on ovarian progesterone production at pro-oestrus and during pregnancy: A possible dual regulation of the biosynthesis of progesterone. J. Reprod. Fertil. 1994, 102:379-384.
327. Singh G., Singh M.M., Maitra S.C., Elger W., Kalra V., Upadhyay S.N., Chowdhury S.R., Kamboj V.P. Luteolytic actions of two antiprogestational agents (RU-38486 and ZK-98734) in the rat. J. Reprod. Fertil. 1988, 83:73-83.
328. Telleria C.M., Goyeneche A.A., Cavicchia J.C., Stati A.O., Deis R.P. Apoptosis induced by antigestagen RU486 in rat corpus luteum of pregnancy. Endocrine 2001, 15:147-155.
329. Ottander U., Hosokawa K., Liu K., Bergh A., Ny T., Olofsson J.I. A putative stimulatory role of progesterone acting via progesterone receptors in the steroidogenic cells of the human corpus luteum. Biol. Reprod. 2000, 62:655-663.
330. Duffy D.M., Stouffer R.L. Gonadotropin versus steroid regulation of the corpus luteum of the rhesus monkey during simulated early pregnancy. Biol. Reprod. 1997, 57:1451-1460.
331. Iwai T., Nanbu Y., Iwai H., Taii S., Fujii S., Mori T. Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch. Pathol. Anat. Histopathol. 1990, 417:369-375.
332. Suzuki T., Sasano H., Kimura N., Tamura M., Fukaya T., Yajima A., Nagura H. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: Relationship to expression of steroidogenic enzymes. Hum. Reprod. 1994, 9:1589-1595.
333. Revelli A., Pacchioni D., Cassoni P., Bussolati G., Massobrio M. In situ hybridization study of messenger RNA for estrogen receptor and immunohistochemical detection of estrogen and progesterone receptors in the human ovary. Gynaecol. Endocrinol. 1996, 10:177-186.
334. Misao R., Nakanishi Y., Iwagaki S., Fujimoto J., Tamaya T. Expression of progesterone receptor isoforms in corpora lutea of human subjects: Correlation with serum oestrogen and progesterone concentration. Mol. Hum. Reprod. 1998, 4:1045-1052.
335. Duffy D.M., Wells T.R., Haluska G.J., Stouffer R.L. The ratio of progesterone receptor isoforms changes in the monkey corpus luteum during the luteal phase of the menstrual cycle. Biol. Reprod. 1997, 57:693-699.
336. Hild-Petito S., Stouffer R.L., Brenner R.M. Immunocytochemical localization of estrogen and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 1988, 123:2896-2905.
337. Hild-Petito S., Fazleabas A.T. Expression of steroid receptors and steroidogenic enzymes in the baboon (Papio anubis) corpus luteum during the menstrual cycle and early pregnancy. J. Clin. Endocrinol. Metab. 1997, 82:962-995.
338. Duffy D.M., Molskness T.A., Stouffer R.L. Progesterone receptor messenger ribonucleic acid and protein in luteinized granulosa cells of rhesus monkeys are regulated in vitro by gonadotropins and steroids. Biol. Reprod. 1996, 54:888-895.
339. Park-Sarge O.K., Parmer T.G., Gu Y., Gibori G. Does the rat corpus luteum express the progesterone receptor gene?. Endocrinology 1995, 136:1537-1543.
340. Telleria C.M., Stocco C.O., Stati A.O., Deis R.P. Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy. Steroids 1999, 64:760-766.
341. Goyeneche A.A., Deis R.P., Gibori G., Telleria C.M. Progesterone promotes survival of the rat corpus luteum in the absence of cognate receptors. Biol. Reprod. 2003, 68:151-158.
342. Sugino N., Telleria C.M., Gibori G. Progesterone inhibits 20α-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor. Endocrinology 1997, 138:4497-4500.
343. Rae M.T., Menzies G.S., Bramley T.A. Bovine ovarian, non-genomic progesterone binding sites: Presence in follicular and luteal cell membranes. J. Endocrinol. 1998, 159:413-427.
344. Rosenfeld C.S., Wagner J.S., Roberts R.M., Lubahn D.B. Intraovarian actions of oestrogen. Reproduction 2001, 122:215-226.
345. McLean M.P., Khan I., Puryear T.K., Gibori G. Induction and repression of specific estradiol sensitive proteins in the rat corpus luteum. Chin. J. Physiology. 1990, 33:353-366.
346. Rao M.C., Palfrey H.C., Nash N.T., Greisman A., Jayatilak P.G., Gibori G. Effects of estradiol on calcium-specific protein phosphorylation in the rat corpus luteum. Endocrinology 1987, 120:1010-1018.
347. Gibori G., Chen Y.-D.I., Khan I., Azhar S., Reaven G.M. Regulation of luteal cell lipoprotein receptors, sterol content and steroidogenesis by estradiol in the pregnant rat. Endocrinology 1984, 114:609-617.
348. Khan I., Belanger A., Chen Y.-D.I., Gibori G. Influence of high-density lipoprotein on estradiol stimulation of luteal steroidogenesis. Biol. Reprod. 1985, 32:96-104.
349. Townson D.H., Wang X.J., Keyes P.L., Kostyo J.L., Stocco D.M. Expression of the steroidogenic acute regulatory protein in the corpus luteum of the rabbit: Dependence upon the luteotropic hormone, estradiol-17β. Biol. Reprod. 1996, 55:868-874.
350. Cok S.J., Hay R.V., Holt J.A. Estrogen-mediated mitochondrial cholesterol transport and metabolism to pregnenolone in the rabbit luteinized ovary. Biol. Reprod. 1997, 57:360-366.
351. Losordo D.W., Isner J.M. Estrogen and angiogenesis: A review. Arterioscler. Throm. Vasc. Biol. 2001, 21:6-12.
352. Johns A., Freay A.W., Fraser D., Korach K.S., Rubanyi G.M. Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996, 137:4511-4513.
353. Gagliardi A., Collins D.C. Inhibition of angiogenesis by antiestrogens. Cancer Res. 1993, 53:533-535.
354. Guthridge M., Bertolini J., Cowling J., Hearn M.T. Localization of bFGF mRNA in cyclic rat ovary, diethylstilbesterol primed rat ovary, and cultured rat granulosa cells. Growth Factors 1992, 7:15-25.
355. Garrido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 1993, 8:109-117.
356. Cullinan-Bove K., Koos R.D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993, 133:829-837.
357. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., Jaffe R.B., Taylor R.N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 1996, 81:3112-3118.
358. Ye F., Florian M., Magder S.A., Hussain S.N.A. Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen. Steroids 2002, 67:305-310.
359. Davis J.S., Rueda B.R. The corpus luteum: An ovarian structure with maternal instincts and suicidal tendencies. Front Biosci. 2002, 7:1949-1978.
360. 2α-induced expression of 20α-hydroxysteroid dehydrogenase involves the transcription factor NUR77. J. Biol. Chem. 2000, 275:37202-37211.
361. Deis R.P. Induction of lactogenesis and abortion by prostaglandin F2-alpha in pregnant rats. Nature 1971, 229:568.
362. 2 on the corpora lutea of pregnant rats. Biol. Reprod. 1974, 10:24-38.
363. 2α in pregnant rats. J. Steroid. Biochem. 1979, 11:1485-1489.
364. 2α on the progestagen content of ovaries from pseudopregnant rats. Proc. Soc. Exp. Biol. Med. 1969, 130:92-94.
365. 2α. Prostaglandins 1974, 5:73-85.
366. Fuchs A.R., Smitasiri Y., Chantharaksri U. The effect of indomethacin on uterine contractility and luteal regression in pregnant rats at term. J. Reprod. Fertil. 1976, 48:331-340.
367. Sugimoto Y., Yamasaki A., Segi E., Tsuboi K., Aze Y., Nishimura T., Oida H., Yhosida N., Tanaka T., Katsuyama M., Hasumoto K., Murata T., Hirata M., Ushikubi F., Negishi M., Ichikawa A., Narumiya S. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997, 277:681-683.
368. Sugimoto Y., Segi E., Tsuboi K., Ichikawa A., Narumiya S. Female reproduction in mice lacking the prostaglandin F receptor. Roles of prostaglandin and oxytocin receptors in parturition. Adv. Exp. Med. Biol. 1998, 449:317-321.
369. Uozumi N., Kume K., Nagase T., Nakatani N., Ishii S., Tashiro F., Komagata Y., Maki K., Ikuta K., Ouchi Y., Miyazaki J., Shimizu T. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997, 390:618-622.
370. Bonventre J.V., Huang Z., Taheri M.R., O'Leary E., Li E., Moskowitz M.A., Sapirstein A. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997, 390:622-625.
371. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995, 83:483-492.
372. Gross G.A., Imamura T., Luedke C., Vogt S.K., Olson L.M., Nelson D.M., Sadovsky Y., Muglia L.J. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. USA 1998, 95:11875-11879.
373. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol. Rev. 1999, 79:1193-1226.
374. Curlewis J.D., Tam S.P., Lau P., Kusters D.H., Barclay J.L., Anderson S.T., Waters M.J. A prostaglandin F2α analog induces suppressors of cytokine signaling-3 expression in the corpus luteum of the pregnant rat: A potential new mechanism in luteolysis. Endocrinology 2002, 143:3984-3993.
375. Tam S.P., Lau P., Djiane J., Hilton D.J., Waters M.J. Tissue-specific induction of SOCS gene expression by PRL. Endocrinology 2001, 142:5015-5026.
376. 2α induces a rapid decline in progesterone production and steroidogenic acute regulatory protein expression in isolated rat corpus luteum without altering messenger ribonucleic acid expression. Biol. Reprod. 1999, 61:643-650.
377. Pepe G.J., Rothchild I. A comparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. Endocrinology 1974, 95:275-279.
378. Critser E.S., Rutledge J.J., French L.R. Role of the uterus and the conceptus in regulating luteal lifespan in the mouse. Biol. Reprod. 1980, 23:558-563.
379. Duby R.T., McDaniel J.W., Spilman C.H., Black D.L. Utero-ovarian relationships in the golden hamster. I. Ovarian periodicity following hysterectomy. Acta. Endocrinol. (Copenh.) 1969, 60:595-602.
380. 2α increases expression of prostaglandin synthase-2 in the rat corpus luteum. Prostaglandins Other Lipid Mediat. 2002, 70:145-160.
381. Guo K., Wolf V., Dharmarajan A.M., Feng Z., Bielke W., Saurer S., Friis R. Apoptosis-associated gene expression in the corpus luteum of the rat. Biol. Reprod. 1998, 58:739-746.
382. Roughton S.A., Lareu R.R., Bittles A.H., Dharmarajan A.M. Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis. Biol. Reprod. 1999, 60:797-804.
383. Penny L.A. Monocyte chemoattractant protein 1 in luteolysis. Rev. Reprod. 2000, 5:63-66.
384. Goyeneche A.A., Martinez I.L., Deis R.P., Gibori G., Telleria C.M. In vivo hormonal environment leads to differential susceptibility of the corpus luteum to apoptosis in vitro. Biol. Reprod. 2003.